RETRACTION: MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin (Retraction of Vol 12, Pg 759, 2019)

被引：0
作者：
Yin, Z.
Ren, W.
机构：
来源：
ONCOTARGETS AND THERAPY | 2023年 / 16卷
关键词：
D O I：
10.2147/OTT.S427141
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：471 / 471
页数：1
相关论文
共 50 条
[31]   RETRACTION: MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia (Retraction of Vol 5, art no 12460, 2015) [J].
Zhu Xishan ;
Lin Ziying ;
Du Jing ;
Liu Gang .
SCIENTIFIC REPORTS, 2023, 13 (01)
[32]   RETRACTION: miR-196 acts a tumor suppressor in osteosarcoma through targeting HOXA9 (Retraction of Vol 11, Pg 4579, 2018) [J].
Cao, Y. ;
Wu, B. Q. ;
Wang, D. W. ;
Bi, Z. G. .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (06) :786-786
[33]   RETRACTION: MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma (Retraction of Vol 36, Pg 6613, 2015) [J].
Liu, H. ;
Li, W. ;
Chen, C. .
TUMOR BIOLOGY, 2017,
[34]   RETRACTION: LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma (Retraction of Vol 23, Pg 4673, 2019) [J].
Lin, J. ;
Nong, L-L ;
Li, M-Q ;
Yang, F-C ;
Wang, S-H ;
Liu, M-J .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (22) :11467-11467
[35]   RETRACTION: HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells (Retraction of Vol 29, Pg 1438, 2018) [J].
Chi, Chi ;
Mao, Min ;
Shen, Zongji ;
Chen, Youguo ;
Chen, Jie ;
Hou, Wenjie .
HUMAN GENE THERAPY, 2022, 33 (9-10) :572-572
[36]   RETRACTION: MicroRNA-338-3p suppresses tumor growth of esophageal squamous cell carcinoma in vitro and in vivo (Retraction of Vol 12, Pg 3951, 2015) [J].
Li, Xinyu ;
Li, Zhihong ;
Yang, Guiyun ;
Pan, Zhenxiang .
MOLECULAR MEDICINE REPORTS, 2021, 24 (05)
[37]   RETRACTION: LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270 (Retraction of Vol 17, Pg 563, 2019) [J].
Zou, Aimei ;
Liu, Xingli ;
Mai, Zongjiong ;
Zhang, Junke ;
Liu, Zhuohuan ;
Huang, Qilu ;
Wu, Aibing ;
Zhou, Chenyu .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 28 :597-597
[38]   RETRACTION: MicroRNA-34a inhibit hepatocellular carcinoma progression by repressing hexokinase-1 (Retraction of Vol 120, Pg 7147, 2019) [J].
Zhou, Yitong ;
Liu, Kai ;
Liu, Yahui ;
Tan, Ludong .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (02) :494-494
[39]   RETRACTION: microRNA-493 Inhibits Tongue Squamous Cell Carcinoma Oncogenicity via Directly Targeting HMGA2 (Retraction of Vol 12, Pg 6947, 2019) [J].
Jiao, D. ;
Liu, Y. ;
Tian, Z. .
ONCOTARGETS AND THERAPY, 2021, 14 :4737-4737
[40]   RETRACTION: MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM (Retraction of Vol 9, art no E114585, 2014) [J].
Chong, Y. .
PLOS ONE, 2022, 17 (06)
12345